Effect and safety of Chinese patent medicine capsules for recurrent angina pectoris after percutaneous coronary intervention: A protocol for systematic review and meta-analysis

INTRODUCTION: Recurrent angina pectoris after percutaneous coronary intervention (PCI) is a common clinical syndrome, which seriously reduces the quality of life and health of patients, increases medical costs, and causes the risk of cardiogenic death. The efficacy of various western medicine improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yize, Wang, Zheyi, Wang, Chao, Tang, Zhuoran, Shi, Jinyu, Zhao, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717720/
https://www.ncbi.nlm.nih.gov/pubmed/33285705
http://dx.doi.org/10.1097/MD.0000000000023287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717720/
https://www.ncbi.nlm.nih.gov/pubmed/33285705
http://dx.doi.org/10.1097/MD.0000000000023287

Ejemplares similares